Site Map Icon
RSS Feed icon
March 22, 2018

Important Links
Retired Firefighters Association of Denver
History of IAFF
Denver Fire Fighters Burn Foundation
Hearts of Fire
Denver Fire Running
Fire & Police Pension Association
Denver Fire Department Credit Union
Denver Fire Fighters Museum
Deferred Compensation Plan
Kaiser Permanente Health Care
Mesothelioma Resource Online
Mesothelioma Assistance
Mesothelioma Lawyer Center
Fire Fighter Near Miss Reporting
Cooney & Associates-Hartford
Colorado State Legislature
United States Senate
Friends Of The Denver Fire Department

Denver Fire Online

Departmental Vacation Pick Access


Union Made Products and Boycott List

FDA Approves Radicava to Treat ALS
Posted On: May 11, 2017

I have some exciting news to share with you: The FDA just approved the first drug in 22 years to treat ALS - the second treatment ever for the disease. Edaravone (brand name Radicava) is an anti-oxidant drug thought to preserve motor neurons in people with ALS, allowing the nerves to keep their muscles working for a longer period of time.

This exciting announcement comes during ALS Awareness Month, a special time to honor families and rally individuals as MDA continues to lead the fight against this devastating disease. We are currently supporting important research efforts to help bring additional learnings and treatments to ALS families, including the following:

*        Jie Jiang, Ph.D., is conducting studies to improve understanding of disease mechanisms underlying the most common inherited form of ALS.
*        Jiou Wang, M.D., Ph.D., is working to identify how protein quality control goes awry in ALS.
*        Fen-Biao Gao, Ph.D., is working to identify what leads to DNA damage in ALS and develop new drug targets for the disease.
*        Mohamed Farah, Ph.D., is investigating whether a drug currently in development for Alzheimer's disease can improve function in ALS.
*        Eric Shoubridge, Ph.D., is studying a new gene linked to ALS.

These research projects are the five newest of 44 active ALS projects MDA currently is supporting, with a total current funding commitment of $11.4 million. Since its inception, MDA has invested more than $363 million in ALS research and support services.

For more on the drug approval, read FDA Approves Radicava to Treat ALS<>, and be sure to check back at <> <> for updates.

Thank you, as always, for your continued support of MDA families.

All the best,

Lindsay Molloy
Associate Executive Director
Muscular Dystrophy Association
720 S Colorado Blvd. #380-S
Denver, CO 80246
o: 303.691.3331 <tel:303.691.3331>  | c: 303.810.9480 <tel:303.810.9480>

Follow us online: <> <> * <>


Member Login


Not registered yet?
Click Here to sign-up

Forgot Your Login?

The next


will be


April 11th


7:00 p.m.




April 12th


8:30 a.m.


12 Lakeside Lane

Door Prize



IAFF Local Newswire
Join the Newswire!
Updated: Mar. 22 (15:10)
Local 3169 Hosts CPR & Stop the Bleed Programs
IAFF Local 3169
Local 858 Car Show 6/23!
Denver Firefighters Local 858
Annual Retirement and Awards Banquet
IAFF Local 739
2018 MDA Bowling Event
Foxborough Professional Fire Fighters
Gina Galetti Scholarship
IAFF Local 42
2018 Firefighter's Ball
Newton Fire Fighters Association
Denver Firefighters Local 858
Copyright © 2018, All Rights Reserved.
Powered By UnionActive™

814441 hits since Jul 25, 2011

Top of Page image